Skip to main content
HIT logo

Health In Tech, Inc. (HIT) Stock: Price, Forecast & Analyst Target

Health In Tech, Inc. (HIT) — MoonshotScore 24/100 (Weak band), calculated Nov 18, 2026. Price $0.3406 (-10.39%), as of the Nov 19, 2026 trading session; market cap $27.1M.

Educational signal · not a buy or sell recommendation · How to read this

$0.3406 −$0.0395 (-10.39%) Market Cap $27.1M

Health In Tech, Inc. · HIT · NASDAQ

Health In Tech, Inc. is an insurance technology platform company providing solutions for small businesses. Their offerings include reference-based pricing, a SaaS quoting platform, and tools for managing health insurance and medical records.

Price as of Nov 19, 2026

Key Statistics

24 of 100

MoonshotScore v2 · Health In Tech (HIT)

Weak
Business Quality Poor (13)
Financial Safety Fragile (11)
Valuation Bubble (17)
Growth Durability Fading (22)
Momentum Slipping (20)
Why this rating? Method, drivers & history

Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.

  • Business Quality — Is this a genuinely good business?
  • Financial Safety — Could this blow up on me?
  • Valuation — Am I paying a fair price?
  • Growth Durability — Is the growth real and likely to last?
  • Momentum — Is the market already moving on this?
The ten-second read ·

Bottom-tier quality, a fragile balance sheet and stalling growth, and it’s expensive on top — broad distress, a capital-preservation call, not a value entry. The score also carries a risk penalty for a bankruptcy-risk score in the distress zone and losses on top of negative retained earnings. Business Quality: Poor; Financial Safety: Fragile; Valuation: Bubble; Growth Durability: Fading; Momentum: Slipping.

Earnings yield is the main valuation drag relative to sector peers.

  • quarterly revenue $7M (Q3 FY2026, quarter ended Sep 30, 2026)
  • EPS beat 1 of the last 8 reports
  • Altman Z 0.00 · Piotroski F 1

Holding back: weak fundamentals, balance-sheet strain, a rich price, soft growth, weak price trend

What has the MoonshotScore done over time?

MoonshotScore snapshots recorded for HIT (57 recorded, newest six shown)
RecordedScoreBand
40Weak
39Weak
24Weak
24Weak
24Weak
24Weak

Daily score refresh is delayed. This is the last recorded calculation.

Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.

Computed · How the MoonshotScore is computed →

Price & valuation

Dates shown where recorded
MeasureValueAs of
Latest provided price$0.3406
Change on the day-10.39%
52-week range$0.3406 – $2.10
Market capitalisation$27.1M—
Price / earnings (trailing)67.68
Shares traded on the day128.4K

Price & events

Other perspectives

Council score for Health In Tech (HIT): perspectives

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

5-Factor Breakdown

Business Quality Negative
Financial Safety Negative
Valuation Negative
Growth Durability Weak
Momentum Weak

Legends Council

4 lenses, 0 current

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated) Ray Dalio Favorable read
Englander-style lens (simulated) Izzy Englander Unfavorable read
Klarman-style lens (simulated) Seth Klarman Unfavorable read
Moon AI lens (model) Favorable read

Read on: Oct 7, 2026 · older than the 27 hours refresh window; not a current reading

Munger's Mindset

Balance Sheet & Valuation · historical

Financial Health Neutral
Margin of Safety Fairly Valued
Profit Margin Weak
Revenue Growth Strong
Debt/Equity Strong
ROE Negative
Gross Margin Moderate

Read on: Sep 10, 2026 · older than the 27 hours refresh window; not a current reading

How to read these bars and different assessments

Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.

Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.

On Sep 10, 2026, the Munger lens read the price at that time as fairly valued against its own estimate of value.

Readings on this page are from Nov 20, 2026, except a card that shows its own read date.

1 · What is it?

What is Health In Tech (HIT), and what does it report?

Short answer

A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. Health In Tech, Inc. (HIT) is listed on NASDAQ. It employs 89 people and is led by Sanjay Kumar Shrestha. In Q3 FY2026 it reported revenue of $7M and net income of -$7M. The market values it at $27.1M.

2 · Latest results

What do the latest results show for Health In Tech (HIT)?

Short answer · as of

The most recent reported quarter, Q3 FY2026, carried revenue of $7M. Against analyst estimates the company has EPS beat 1 of the last 8 reports.

Quarterly income statement — 4 quarters
Revenue, net income and earnings per share by quarter
PeriodRevenueNet incomeEPS
Q3 FY2026$7M-$7M-$0.11 (diluted)
Q2 FY2026$8M-$3M-$0.04 (diluted)
Q1 FY2026$9M-$2M-$0.03 (diluted)
Q4 FY2025$8M-$302,557-$0.01 (diluted)
3 · Financial strengths and risks

What are the financial strengths and risks for Health In Tech (HIT)?

Short answer · as of

What is holding it back is weak fundamentals, balance-sheet strain, a rich price, soft growth, weak price trend. The distress and quality screens read Altman Z 0.00 · Piotroski F 1. Trailing ratios: ROE -64.5% · ROA -40.9% · current ratio 1.12 · earnings yield -46.0% · free-cash-flow yield -35.7%.

Data-derived red flags

  • Listing risk — at $0.3406 the shares sit below the $1.00 minimum bid NASDAQ requires for continued listing.
  • Financial-distress signal — its Altman Z-Score of 0.00 sits in the distress zone (elevated bankruptcy risk).
  • Negative return on equity (-64.5%) — the business is not currently generating profit on shareholder capital.
4 · What to check next?

What should you watch next at Health In Tech (HIT)?

Short answer · as of

Current published price targets run low $3.00 · high $3.00 · consensus $3.00 · median $3.00 against a quoted price of $0.3406 (as of Nov 19, 2026).

What the records here don't tell us

  • No forward revenue or earnings estimate is on file.
  • The next earnings date is not yet scheduled in the calendar we read.
  • No insider Form 4 transaction falls inside the window this page reads.

Checked against the records this page reads, on the dates shown above.

5 · Peer comparison

How does Health In Tech compare with its peers?

Short answer

Health In Tech's score ranks 13th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.

Peer set — price, market value and MoonshotScore
CompanyPriceMarket valueScore
Upbound Group, Inc. (UPBD) Same industry, near in market value$24.87 Nov 19, 2026$1.45B90 5-pillar Nov 18, 2026
Docebo Inc. (DCBO) Same industry, near in market value$30.13 Nov 18, 2026$753M87 5-pillar Nov 18, 2026
Red Violet, Inc. (RDVT) Same industry, near in market value$70.99 Nov 18, 2026$1.14B87 5-pillar Nov 18, 2026
Vtex (VTEX) Same industry, near in market value$3.44 Nov 18, 2026$560M85 5-pillar Nov 18, 2026
Mitek Systems, Inc. (MITK) Same industry, near in market value$17.49 Nov 18, 2026$789M82 5-pillar Nov 18, 2026
Humana Inc. (HUM) Named competitor$380.00 Nov 19, 2026$45.6B79 5-pillar Nov 18, 2026
Where Food Comes From, Inc. (WFCF) Same industry, near in market value$14.16 Nov 18, 2026$70.3M78 5-pillar Nov 18, 2026
PagerDuty, Inc. (PD) Same industry, near in market value$15.80 Nov 18, 2026$1.24B78 5-pillar Nov 18, 2026
Intellicheck, Inc. (IDN) Same industry, near in market value$1.79 Nov 18, 2026$36.6M77 5-pillar Nov 18, 2026
Immersion Corporation (IMMR) Same industry, near in market value$6.83 Nov 18, 2026$227M77 5-pillar Nov 18, 2026
UnitedHealth Group Incorporated (UNH) Named competitor$349.91 Nov 18, 2026$314B76 5-pillar Nov 18, 2026
Materialise NV (MTLS) Same industry, near in market value$6.31 Nov 19, 2026$360M76 5-pillar Nov 18, 2026
Health In Tech (HIT) — this page$0.3406$27.1M24

Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.

The records behind this page

Analyst targets & estimates

What analysts have on file

Price target, low to high
$3.00 – $3.00
Consensus target
$3.00
Median target
$3.00

Consensus record · Captured .

Measured against a quoted price of $0.3406 (as of Nov 19, 2026).

Who holds the shares?

Institutional ownership reported through 13F filings.

Tracked investors

Which of the 16 named investors we follow held HIT in their latest 13F filing, and what they did against the filing before it.

None of the 16 tracked investors reported HIT in their latest 13F filing.

See all tracked investor portfolios

How to read these figures

These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.

What has been published about Health In Tech (HIT)?

Read these with our analysis →

Health In Tech Stock: Key Questions Answered

These answers are editorial: 1 of these 9 answers is drawn from the HIT research dossier (written May 10, 2026 by gemini-2.0-flash); the other 8 are question templates that restate figures shown above. Figures in this section are not part of the source register.

What does the MoonshotScore mean for HIT?

HIT carries the MoonshotScore stated above — the Weak band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. Health In Tech, Inc. is an insurance technology platform company providing solutions for small businesses.

Is HIT a good stock to buy?

Stock Expert AI does not rate HIT buy, sell or hold. Health In Tech, Inc. carries a MoonshotScore, in the Weak band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.

What is the HIT stock price today?

The last price recorded for Health In Tech, Inc. (HIT), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.

What is the HIT price target?

The analyst consensus price target for Health In Tech, Inc. (HIT), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.

What are the main risks for HIT?

Health In Tech, Inc. faces several risks, including competition from larger, more established insurance providers with greater resources and brand recognition.

What are the key factors to evaluate for HIT?

Health In Tech, Inc. (HIT) holds a MoonshotScore in the low range. To weigh it, compare the trailing P/E under Price & valuation with the analyst view under Analyst targets & estimates on this page. Not financial advice.

How frequently does HIT data refresh on this page?

HIT's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.

What has driven HIT's recent stock price performance?

Health In Tech, Inc. (HIT) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Innovative technology platform (eDIYBS). See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider HIT overvalued or undervalued right now?

The trailing P/E of Health In Tech, Inc. (HIT) is listed under Price & valuation, and the analyst consensus target under Analyst targets & estimates, on this page. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.

Sources: the source register lists the 21 figures on this page — 12 from Financial Modeling Prep (FMP), 7 with no recorded source and 2 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.

Publication details and research sources
Published
Research standards
Methodology · Editorial policy · Corrections
Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.